Active Ingredient(s): Vibegron
FDA Approved: * December 23, 2020
Pharm Company: * UROVANT
Category: Urinary System

Vibegron, sold under the brand name Gemtesa, is a medication for the treatment of overactive bladder.[1][4][5] Vibegron (other names: RVT-901; MK4618; KRP114V; URO-901) is a selective beta 3 adrenergic receptor agonist. The most common side effects include headache, urinary tract infection, common cold, diarrhea, nausea, and upper respiratory tract infection.[4] It was approved for medical use in the United States in December 202... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Gemtesa 75 mg Oral Tablet, Film Coated
NDC: 73336-075
Urovant Sciences, Inc.

Popular Topics

Gemtesa side effects?

I have both stress and urge incontinence. Just started taking Gemtesa this morning. I would like to know about any exper...